InsiderTrades.com logo

CRVS Insider Trading

Insider Ownership Percentage: 28.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,893,541.12

Corvus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Corvus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Corvus Pharmaceuticals Share Price & Price History

Current Price: $17.82
Price Change: ▲ Price Increase of +0.61 (3.54%)
As of 02/24/2026 05:00 PM ET

This chart shows the closing price history over time for CRVS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Corvus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/27/2025Peter A. ThompsonDirectorSell1,176,332$4.16$4,893,541.127,165,006View SEC Filing Icon  
5/6/2024Richard A. Miller CEOBuy577,634$1.73$999,306.82577,634View SEC Filing Icon  
5/6/2024William Benton JonesInsiderBuy20,000$1.73$34,600.00153,773View SEC Filing Icon  
5/15/2023Linda GraisDirectorBuy10,000$2.45$24,500.0010,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Corvus Pharmaceuticals (NASDAQ:CRVS)

46.64% of Corvus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRVS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Corvus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/19/2026Invesco Ltd.43,583$0.34M0.0%+12.7%0.052%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC31,783$0.25M0.1%+18.4%0.038%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP314,683$2.42M0.0%+74.7%0.376%Search for SEC Filing on Google Icon
2/18/2026RTW Investments LP447,607$3.45M0.0%-83.3%0.534%Search for SEC Filing on Google Icon
2/18/2026Perceptive Advisors LLC692,441$5.33M0.1%-51.9%0.827%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC688,770$5.30M0.0%N/A0.822%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC26,700$0.21M0.0%-60.0%0.032%Search for SEC Filing on Google Icon
2/17/2026Logos Global Management LP500,000$3.85M0.2%N/A0.597%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC465,875$3.59M0.3%N/A0.556%Search for SEC Filing on Google Icon
2/17/2026MPM Bioimpact LLC2,743,671$21.13M2.4%N/A3.275%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD34,105$0.26M0.0%+5.2%0.041%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors11,051$85K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC144,381$1.11M0.0%N/A0.172%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP86,720$0.67M0.0%N/A0.104%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.19,274$0.15M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/17/2026Foresite Capital Management VI LLC1,381,233$10.64M3.2%-20.2%1.649%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC104,820$0.81M0.0%N/A0.125%Search for SEC Filing on Google Icon
2/16/2026Truvestments Capital LLC10,257$79K0.0%+86.1%0.012%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC21,382$0.17M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC394,766$3.04M0.0%+27.7%0.471%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP216,248$1.67M0.0%N/A0.258%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 17,497$0.14M0.0%-6.6%0.021%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC99,724$0.77M0.0%N/A0.119%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.171,173$1.32M0.0%-3.7%0.204%Search for SEC Filing on Google Icon
2/13/2026State Street Corp2,788,223$21.47M0.0%+177.1%3.328%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN62,623$0.48M0.0%+72.1%0.075%Search for SEC Filing on Google Icon
2/12/2026DRW Securities LLC23,384$0.18M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC30,782$0.24M0.0%-8.4%0.037%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.61,318$0.47M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/11/2026DCF Advisers LLC729,000$5.61M1.5%N/A0.870%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG56,039$0.43M0.0%+4.5%0.067%Search for SEC Filing on Google Icon
2/11/2026Fox Run Management L.L.C.11,220$86K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.553,327$4.26M0.0%+24.2%0.661%Search for SEC Filing on Google Icon
2/10/2026AXQ Capital LP12,601$97K0.0%-53.4%0.015%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC35,973$0.28M0.0%+37.5%0.043%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,473,026$11.35M0.0%+1.1%1.758%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC13,764$0.11M0.0%+7.7%0.016%Search for SEC Filing on Google Icon
2/4/2026Towerview LLC140,000$1.08M0.8%-17.6%0.167%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.18,169$0.14M0.0%+39.1%0.022%Search for SEC Filing on Google Icon
1/26/2026Shelton Wealth Management LLC15,638$0.12M0.1%+13.8%0.021%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.3,629$28K0.0%+26.0%0.005%Search for SEC Filing on Google Icon
1/21/2026Palumbo Wealth Management LLC26,255$0.20M0.0%+11.2%0.035%Search for SEC Filing on Google Icon
1/21/2026Sowell Financial Services LLC17,000$0.13M0.0%+41.7%0.023%Search for SEC Filing on Google Icon
1/16/2026Tema Etfs LLC79,698$0.61M0.0%+34.6%0.107%Search for SEC Filing on Google Icon
1/16/2026Empirical Financial Services LLC d.b.a. Empirical Wealth Management167,400$1.29M0.0%-1.1%0.224%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC20,021$0.15M0.0%N/A0.027%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.32,232$0.24M0.0%+6.0%0.043%Search for SEC Filing on Google Icon
11/17/2025Quarry LP3,653$27K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.27,525$0.20M0.0%-4.0%0.037%Search for SEC Filing on Google Icon
11/17/2025Jain Global LLC27,618$0.20M0.0%N/A0.037%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP15,300$0.11M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE151,966$1.12M0.0%+14.5%0.203%Search for SEC Filing on Google Icon
11/14/2025Creative Planning25,299$0.19M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/14/2025Ancora Advisors LLC47,290$0.35M0.0%+9.7%0.063%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP203,360$1.50M0.0%-9.2%0.272%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG162,074$1.19M0.0%+80.7%0.217%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets12,516$92K0.0%+125.9%0.017%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.6,661$49K0.0%N/A0.009%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC309,152$2.28M0.0%-10.0%0.414%Search for SEC Filing on Google Icon
11/10/2025Palumbo Wealth Management LLC23,614$0.17M0.0%N/A0.032%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP27,051$0.20M0.1%N/A0.036%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.13,061$96K0.0%-15.7%0.017%Search for SEC Filing on Google Icon
11/7/2025NEOS Investment Management LLC59,202$0.44M0.0%N/A0.079%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP401,407$2.96M0.2%+25.9%0.538%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.3,471,925$25.59M0.0%+5.8%4.649%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.32,232$0.24M0.0%+6.0%0.043%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers82,590$0.61M0.0%+8.7%0.111%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund18,800$0.14M0.0%-21.0%0.025%Search for SEC Filing on Google Icon
10/20/2025Masso Torrence Wealth Management Inc.17,000$0.13M0.1%-66.0%0.023%Search for SEC Filing on Google Icon
10/9/2025Shelton Wealth Management LLC13,742$0.10M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/28/2025China Universal Asset Management Co. Ltd.15,488$62K0.0%+20.2%0.021%Search for SEC Filing on Google Icon
8/27/2025Squarepoint Ops LLC138,462$0.55M0.0%+37.0%0.186%Search for SEC Filing on Google Icon
8/15/2025Sender Co & Partners Inc.12,995$52K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/15/2025Perceptive Advisors LLC1,438,595$5.75M0.5%N/A1.931%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC66,700$0.27M0.0%+61.5%0.090%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE132,729$0.53M0.0%+34.7%0.178%Search for SEC Filing on Google Icon
8/14/2025Orbimed Advisors LLC7,165,006$28.66M0.8%+3.2%9.616%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC10,118$40K0.0%-96.2%0.014%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.124,496$0.50M0.0%+15.1%0.167%Search for SEC Filing on Google Icon
8/14/2025Bayesian Capital Management LP17,500$70K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.28,661$0.12M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/14/2025Caption Management LLC21,827$87K0.0%-56.3%0.029%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 19,098$76K0.0%N/A0.026%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd43,969$0.18M0.0%-90.2%0.059%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP201,651$0.81M0.0%+30.3%0.271%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.40,607$0.16M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund23,800$95K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/13/2025Hsbc Holdings PLC84,273$0.33M0.0%N/A0.113%Search for SEC Filing on Google Icon
8/12/2025Foresite Capital Management VI LLC1,731,233$6.93M3.9%+9.5%2.323%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers75,950$0.30M0.0%+9,501.8%0.102%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.30,420$0.12M0.0%+541.9%0.041%Search for SEC Filing on Google Icon
8/11/2025BML Capital Management LLC118,766$0.48M0.4%N/A0.159%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC25,778$0.10M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/8/2025Police & Firemen s Retirement System of New Jersey12,258$49K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC1,361,740$5.45M0.0%+130.7%1.998%Search for SEC Filing on Google Icon
8/7/2025ProShare Advisors LLC13,620$54K0.0%N/A0.020%Search for SEC Filing on Google Icon
8/6/2025Towerview LLC170,000$0.68M0.5%+33.3%0.249%Search for SEC Filing on Google Icon
7/21/2025Empirical Financial Services LLC d.b.a. Empirical Wealth Management168,000$0.67M0.0%N/A0.246%Search for SEC Filing on Google Icon
7/14/2025Masso Torrence Wealth Management Inc.50,000$0.20M0.1%+42.9%0.073%Search for SEC Filing on Google Icon
5/16/2025Samlyn Capital LLC4,065,935$12.93M0.2%-39.0%5.964%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Corvus Pharmaceuticals logo
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.
Read More on Corvus Pharmaceuticals

Today's Range

Now: $17.82
Low: $17.15
High: $18.19

50 Day Range

MA: $13.82
Low: $6.50
High: $25.52

52 Week Range

Now: $17.82
Low: $2.54
High: $26.95

Volume

1,170,869 shs

Average Volume

4,978,980 shs

Market Capitalization

$1.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Corvus Pharmaceuticals?

Corvus Pharmaceuticals' top insider shareholders include:
  1. Peter A Thompson (Director)
  2. Richard A Md Miller (CEO)
  3. William Benton Jones (Insider)
Learn More about top insider investors at Corvus Pharmaceuticals.

Who are the major institutional investors of Corvus Pharmaceuticals?

Corvus Pharmaceuticals' top institutional shareholders include:
  1. State Street Corp — 3.33%
  2. MPM Bioimpact LLC — 3.28%
  3. Geode Capital Management LLC — 1.76%
  4. Foresite Capital Management VI LLC — 1.65%
  5. DCF Advisers LLC — 0.87%
  6. Perceptive Advisors LLC — 0.83%
Learn More about top institutional investors of Corvus Pharmaceuticals stock.

Which major investors are selling Corvus Pharmaceuticals stock?

Within the previous quarter, CRVS stock was sold by these institutional investors:
  1. RTW Investments LP
  2. Perceptive Advisors LLC
  3. Foresite Capital Management VI LLC
  4. Bridgeway Capital Management LLC
  5. Towerview LLC
  6. AXQ Capital LP
  7. Charles Schwab Investment Management Inc.
  8. Toronto Dominion Bank

Which major investors are buying Corvus Pharmaceuticals stock?

During the last quarter, CRVS stock was acquired by institutional investors including:
  1. MPM Bioimpact LLC
  2. State Street Corp
  3. DCF Advisers LLC
  4. Millennium Management LLC
  5. Logos Global Management LP
  6. ADAR1 Capital Management LLC
  7. Marshall Wace LLP
  8. Fred Alger Management LLC
Within the previous year, these company insiders have bought Corvus Pharmaceuticals stock:
  1. Peter A Thompson (Director)
  2. Richard A Md Miller (CEO)
Learn More investors buying Corvus Pharmaceuticals stock.